Signaling angiogenesis via p42/p44 MAP kinase and hypoxia

被引:177
作者
Berra, E [1 ]
Milanini, J [1 ]
Richard, DE [1 ]
Le Gall, M [1 ]
Viñals, F [1 ]
Gothié, E [1 ]
Roux, D [1 ]
Pagès, G [1 ]
Pouysségur, J [1 ]
机构
[1] Ctr Antoine Lacassagne, CNRS, UMR 6543, Inst Signaling Dev Biol & Canc Res, F-06189 Nice, France
关键词
VEGF promoter; p42/p44 MAP kinases; hypoxia; HIF-1; angiogenesis; apoptosis;
D O I
10.1016/S0006-2952(00)00423-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Angiogenesis is associated with a number of pathological situations. In this study, we have focused our attention on the role of p42/p44 MAP (mitogen-activated protein) kinases and hypoxia in the control of angiogenesis. We demonstrate that p42/p44 MAP kinases play a pivotal role in angiogenesis by exerting a determinant action at three levels: i) persistent activation of p42/p44 MAP kinases abrogates apoptosis; ii) p42/p44 MAP kinase activity is critical for controlling proliferation and growth arrest of confluent endothelial cells; and iii) p42/p44 MAP kinases promote VEGF (vascular endothelial growth factor) expression by activating its transcription via recruitment of the AP-2/Sp1 (activator protein-2) complex on the proximal region (-88/-66) of the VEGF promoter and by direct phosphorylation of hypoxia-inducible factor 1 alpha (HIF-1 alpha). HIF-1 alpha plays a crucial role in the control of HIF-1 activity, which mediates hypoxia-induced VEGF expression. We show that oxygen-regulated HIF-1 alpha protein levels are not affected by intracellular localisation (nucleus versus cytoplasm). Finally, we propose a model which suggests an autoregulatory feedback mechanism controlling HIF-1 alpha and therefore HIF-1 dependent gene expression. BIOCHEM PHARMACOL 60;8:1171-1178, 2000. (C) 2000 Elsevier Science Inc.
引用
收藏
页码:1171 / 1178
页数:8
相关论文
共 58 条
  • [1] VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS
    BERSE, B
    BROWN, LF
    VANDEWATER, L
    DVORAK, HF
    SENGER, DR
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) : 211 - 220
  • [2] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [3] HOW MAP KINASES ARE REGULATED
    COBB, MH
    GOLDSMITH, EJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (25) : 14843 - 14846
  • [4] Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
    Enholm, B
    Paavonen, K
    Ristimaki, A
    Kumar, V
    Gunji, Y
    Klefstrom, J
    Kivinen, L
    Laiho, M
    Olofsson, B
    Joukov, V
    Eriksson, U
    Alitalo, K
    [J]. ONCOGENE, 1997, 14 (20) : 2475 - 2483
  • [5] Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
    Ferrara, N
    CarverMoore, K
    Chen, H
    Dowd, M
    Lu, L
    OShea, KS
    PowellBraxton, L
    Hillan, KJ
    Moore, MW
    [J]. NATURE, 1996, 380 (6573) : 439 - 442
  • [6] FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
  • [7] ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE
    FOLKMAN, J
    [J]. NATURE MEDICINE, 1995, 1 (01) : 27 - 31
  • [8] WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT
    FOLKMAN, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01): : 4 - 6
  • [9] ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM
    FONG, GH
    ROSSANT, J
    GERTSENSTEIN, M
    BREITMAN, ML
    [J]. NATURE, 1995, 376 (6535) : 66 - 70
  • [10] Forsythe JA, 1996, MOL CELL BIOL, V16, P4604